Comments
Loading...

Hims & Hers Health Analyst Ratings

HIMSNYSE
Logo brought to you by Benzinga Data
$56.33
3.566.75%
At close: -
$56.46
0.130.23%
After Hours: Jun 6, 7:59 PM EDT
ZAVA announced it will be acquired by Hims & Hers Health (HIMS) on Tuesday, June 3, 2025
Consensus Rating1
Buy
Highest Price Target1
$68.00
Lowest Price Target1
$10.00
Consensus Price Target1
$30.44

Hims & Hers Health Analyst Ratings and Price Targets | NYSE:HIMS | Benzinga

Hims & Hers Health Inc has a consensus price target of $30.44 based on the ratings of 19 analysts. The high is $68 issued by Canaccord Genuity on February 19, 2025. The low is $10 issued by Baird on April 11, 2023. The 3 most-recent analyst ratings were released by Needham, Piper Sandler, and Citigroup on June 4, 2025, May 6, 2025, and May 6, 2025, respectively. With an average price target of $44.67 between Needham, Piper Sandler, and Citigroup, there's an implied -20.89% downside for Hims & Hers Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
3
2
Feb
3
Mar
1
2
Apr
1
1
1
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Piper Sandler
Citigroup
B of A Securities
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Hims & Hers Health

Buy NowGet Alert
06/04/2025Buy Now15.13%Needham
Ryan MacDonald64%
$61 → $65MaintainsBuyGet Alert
05/06/2025Buy Now-30.92%Piper Sandler
Korinne Wolfmeyer54%
$35 → $39ReiteratesNeutral → NeutralGet Alert
05/06/2025Buy Now-46.86%Citigroup
Daniel Grosslight39%
$25 → $30MaintainsSellGet Alert
05/06/2025Buy Now8.04%Needham
Ryan MacDonald64%
$61 → $61ReiteratesBuy → BuyGet Alert
04/29/2025Buy Now-53.95%B of A Securities
Allen Lutz54%
$22 → $26MaintainsUnderperformGet Alert
04/29/2025Buy Now-29.15%Morgan Stanley
Craig Hettenbach59%
$60 → $40MaintainsEqual-WeightGet Alert
04/29/2025Buy Now-46.86%TD Cowen
Jonna Kim63%
$44 → $30DowngradeBuy → HoldGet Alert
04/25/2025Buy Now-55.72%Citigroup
Daniel Grosslight39%
$27 → $25MaintainsSellGet Alert
04/10/2025Buy Now-41.55%Truist Securities
Jailendra Singh36%
$39 → $33MaintainsHoldGet Alert
03/18/2025Buy Now-61.03%B of A Securities
Allen Lutz54%
$21 → $22MaintainsUnderperformGet Alert
03/06/2025Buy Now-62.8%B of A Securities
Allen Lutz54%
$21 → $21ReiteratesUnderperform → UnderperformGet Alert
03/06/2025Buy Now-52.18%Citigroup
Daniel Grosslight39%
$27 → $27ReiteratesSell → SellGet Alert
02/26/2025Buy Now-30.92%Truist Securities
Jailendra Singh36%
$24 → $39MaintainsHoldGet Alert
02/25/2025Buy Now-29.15%Leerink Partners
Michael Cherny78%
$24 → $40MaintainsMarket PerformGet Alert
02/25/2025Buy Now-38.01%Piper Sandler
Korinne Wolfmeyer54%
$24 → $35MaintainsNeutralGet Alert
02/25/2025Buy Now8.04%Needham
Ryan MacDonald64%
$31 → $61MaintainsBuyGet Alert
02/25/2025Buy Now-52.18%Citigroup
Daniel Grosslight39%
$25 → $27MaintainsSellGet Alert
02/20/2025Buy Now-62.8%B of A Securities
Allen Lutz54%
$18 → $21MaintainsUnderperformGet Alert
02/19/2025Buy Now20.44%Canaccord Genuity
Maria Ripps73%
$38 → $68MaintainsBuyGet Alert
02/18/2025Buy Now6.27%Morgan Stanley
Craig Hettenbach59%
$42 → $60DowngradeOverweight → Equal-WeightGet Alert
01/10/2025Buy Now-55.72%Citigroup
Daniel Grosslight39%
$24 → $25DowngradeNeutral → SellGet Alert
01/07/2025Buy Now-38.01%BTIG
David Larsen47%
→ $35Initiates → BuyGet Alert
01/06/2025Buy Now-57.49%Piper Sandler
Korinne Wolfmeyer54%
$21 → $24MaintainsNeutralGet Alert
01/06/2025Buy Now-45.09%Needham
Ryan MacDonald64%
$28 → $31MaintainsBuyGet Alert
12/17/2024Buy Now-25.61%Morgan Stanley
Craig Hettenbach59%
→ $42Initiates → OverweightGet Alert
12/02/2024Buy Now-32.69%Canaccord Genuity
Maria Ripps73%
$28 → $38MaintainsBuyGet Alert
11/20/2024Buy Now-50.41%TD Cowen
Jonna Kim63%
$28 → $28ReiteratesBuy → BuyGet Alert
11/14/2024Buy Now-68.12%B of A Securities
Allen Lutz54%
$32 → $18DowngradeBuy → UnderperformGet Alert
11/08/2024Buy Now-50.41%TD Cowen
Jonna Kim63%
$25 → $28MaintainsBuyGet Alert
11/06/2024Buy Now-52.18%Deutsche Bank
George Hill60%
$23 → $27MaintainsHoldGet Alert
11/05/2024Buy Now-62.8%Piper Sandler
Korinne Wolfmeyer54%
$18 → $21ReiteratesNeutral → NeutralGet Alert
11/05/2024Buy Now-50.41%Canaccord Genuity
Maria Ripps73%
$24 → $28MaintainsBuyGet Alert
10/21/2024Buy Now-55.72%B of A Securities
Michael Cherny78%
$23 → $25MaintainsBuyGet Alert
10/14/2024Buy Now-59.26%B of A Securities
Michael Cherny78%
$20 → $23MaintainsBuyGet Alert
09/13/2024Buy Now-64.58%B of A Securities
Michael Cherny78%
$24 → $20MaintainsBuyGet Alert
08/22/2024Buy Now-57.49%Needham
Ryan MacDonald64%
→ $24Initiates → BuyGet Alert
08/07/2024Buy Now-59.26%Deutsche Bank
George Hill60%
$16 → $23MaintainsHoldGet Alert
08/06/2024Buy Now-68.12%Piper Sandler
Korinne Wolfmeyer54%
$18 → $18ReiteratesNeutral → NeutralGet Alert
07/18/2024Buy Now-59.26%Truist Securities
Jailendra Singh36%
$13 → $23MaintainsHoldGet Alert
07/11/2024Buy Now-55.72%TD Cowen
Jonna Kim63%
$15 → $25MaintainsBuyGet Alert
07/11/2024Buy Now-68.12%Piper Sandler
Korinne Wolfmeyer54%
$16 → $18MaintainsNeutralGet Alert
06/27/2024Buy Now-59.26%Jefferies
Glen Santangelo51%
$14 → $23MaintainsHoldGet Alert
06/13/2024Buy Now-53.95%B of A Securities
Michael Cherny78%
$22 → $26MaintainsBuyGet Alert
06/03/2024Buy Now-61.03%B of A Securities
Michael Cherny78%
$17.25 → $22MaintainsBuyGet Alert
05/22/2024Buy Now-57.49%Canaccord Genuity
Maria Ripps73%
$20 → $24MaintainsBuyGet Alert
05/22/2024Buy Now-64.58%Citigroup
Daniel Grosslight39%
$16 → $20DowngradeBuy → NeutralGet Alert
05/07/2024Buy Now-71.66%Deutsche Bank
George Hill60%
$14 → $16MaintainsHoldGet Alert
05/07/2024Buy Now-76.97%Piper Sandler
Korinne Wolfmeyer54%
$11 → $13MaintainsNeutralGet Alert
04/16/2024Buy Now-73.43%Jefferies
Glen Santangelo51%
$17 → $15DowngradeBuy → HoldGet Alert
04/10/2024Buy Now-64.58%Canaccord Genuity
Maria Ripps73%
→ $20Initiates → BuyGet Alert
02/27/2024Buy Now-69.89%Guggenheim
Jack Wallace56%
$15 → $17MaintainsBuyGet Alert
02/27/2024Buy Now-71.66%Citigroup
Daniel Grosslight39%
$12 → $16MaintainsBuyGet Alert
02/27/2024Buy Now-80.52%Piper Sandler
Michael Lavery66%
$9 → $11MaintainsNeutralGet Alert
02/27/2024Buy Now-76.97%Truist Securities
Jailendra Singh36%
$10 → $13MaintainsHoldGet Alert
02/26/2024Buy Now-82.29%Leerink Partners
Michael Cherny78%
→ $10Initiates → Market PerformGet Alert
01/05/2024Buy Now-73.43%Tigress Financial
Ivan Feinseth74%
$14 → $15MaintainsBuyGet Alert
08/09/2023Buy Now-82.29%Truist Securities
Jailendra Singh36%
$12 → $10MaintainsHoldGet Alert
08/08/2023Buy Now-75.2%Credit Suisse
Jonathan Yong65%
→ $14ReiteratesOutperform → OutperformGet Alert
07/28/2023Buy Now-80.52%TD Cowen
Jonna Kim63%
→ $11Initiates → OutperformGet Alert
06/15/2023Buy Now-75.2%Tigress Financial
Ivan Feinseth74%
$12 → $14Reiterates → BuyGet Alert
05/30/2023Buy Now-80.52%Piper Sandler
Michael Lavery66%
$12 → $11MaintainsNeutralGet Alert
05/09/2023Buy Now-73.43%B of A Securities
Michael Cherny78%
$13.5 → $15MaintainsBuyGet Alert
05/09/2023Buy Now-78.75%Piper Sandler
Michael Lavery66%
$11 → $12MaintainsNeutralGet Alert
04/27/2023Buy Now-68.12%Guggenheim
Jack Wallace56%
$15 → $18MaintainsBuyGet Alert
04/26/2023Buy Now-80.52%Piper Sandler
Korinne Wolfmeyer54%
$10 → $11MaintainsNeutralGet Alert
04/11/2023Buy Now-82.29%Baird
Vikram Kesavabhotla54%
→ $10Initiates → NeutralGet Alert
03/01/2023Buy Now-75.2%Credit Suisse
Jonathan Yong65%
$8 → $14MaintainsOutperformGet Alert
02/28/2023Buy Now-73.43%Guggenheim
Jack Wallace56%
→ $15Reiterates → BuyGet Alert
02/28/2023Buy Now-78.75%Truist Securities
Jailendra Singh36%
$7 → $12MaintainsHoldGet Alert
02/28/2023Buy Now-75.2%Citigroup
Daniel Grosslight39%
$9 → $14MaintainsBuyGet Alert
02/28/2023Buy Now-82.29%Piper Sandler
Korinne Wolfmeyer54%
$7 → $10MaintainsNeutralGet Alert
02/28/2023Buy Now-76.09%B of A Securities
Michael Cherny78%
$11.5 → $13.5MaintainsBuyGet Alert
02/09/2023Buy Now-80.52%Jefferies
Glen Santangelo51%
$7 → $11UpgradeHold → BuyGet Alert
01/12/2023Buy Now-78.75%Tigress Financial
Ivan Feinseth74%
$11 → $12MaintainsBuyGet Alert
11/08/2022Buy Now-84.94%B of A Securities
Michael Cherny78%
$7.5 → $8.5UpgradeNeutral → BuyGet Alert
11/08/2022Buy NowSVB Leerink
Joy Zhang26%
UpgradeUnderperform → Market PerformGet Alert
10/17/2022Buy Now-89.37%Piper Sandler
Korinne Wolfmeyer54%
$8 → $6DowngradeOverweight → NeutralGet Alert
09/07/2022Buy Now-87.6%Truist Securities
Jailendra Singh36%
→ $7Initiates → HoldGet Alert
08/10/2022Buy Now-85.83%Credit Suisse
Jonathan Yong65%
$7 → $8MaintainsOutperformGet Alert
08/09/2022Buy Now-91.14%SVB Leerink
Joy Zhang26%
$4 → $5MaintainsUnderperformGet Alert
07/15/2022Buy Now-92.92%SVB Leerink
Joy Zhang26%
→ $4Initiates → UnderperformGet Alert

FAQ

Q

What is the target price for Hims & Hers Health (HIMS) stock?

A

The latest price target for Hims & Hers Health (NYSE:HIMS) was reported by Needham on June 4, 2025. The analyst firm set a price target for $65.00 expecting HIMS to rise to within 12 months (a possible 15.13% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE:HIMS) was provided by Needham, and Hims & Hers Health maintained their buy rating.

Q

When was the last upgrade for Hims & Hers Health (HIMS)?

A

The last upgrade for Hims & Hers Health Inc happened on February 9, 2023 when Jefferies raised their price target to $11. Jefferies previously had a hold for Hims & Hers Health Inc.

Q

When was the last downgrade for Hims & Hers Health (HIMS)?

A

The last downgrade for Hims & Hers Health Inc happened on April 29, 2025 when TD Cowen changed their price target from $44 to $30 for Hims & Hers Health Inc.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on June 4, 2025 so you should expect the next rating to be made available sometime around June 4, 2026.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $61.00 to $65.00. The current price Hims & Hers Health (HIMS) is trading at is $56.46, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.